STONKWHISPER
← Back to Intel
Insider ActivityRAPP

Yeleswaram Krishnaswamy, Chief Development Officer at Rapport Therapeutics, Inc., sold $321K of RAPP

Updated Jun 18, 2026
Yeleswaram Krishnaswamy Chief Development Officer
Rapport Therapeutics, Inc. · $RAPP
$321K Total Value
9,165 Shares Traded
$34.974 Price / Share
276,851 Shares Owned After
2026-04-14 Filing Date

Transaction Details

InsiderYeleswaram Krishnaswamy
TitleChief Development Officer
CompanyRapport Therapeutics, Inc.
TickerRAPP
Transaction TypeSale
Transaction Date2026-04-13
Shares Traded9,165
Price Per Share$34.974
Total Value$321K
Filed Date2026-04-14
Accession Number0001193125-26-154908

Ownership Context

Shares Owned After Transaction276,851
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-154908

Other Insider Trades — RAPP

Other Trades by Yeleswaram Krishnaswamy

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for RAPP — Rapport Therapeutics, Inc. →

Track RAPP insider activity in real time on The Wire →

Get alerts when Yeleswaram Krishnaswamy files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:21 UTC

Want real-time data? Access The Wire for live sentiment tracking.